HCR Wealth Advisors’s Inhibrx, Inc. Common Stock INBX Stock Holding History

HCR Wealth Advisors’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-6,300	Closed	-$220K	–	234
2024 Q1	$220K	Hold	6,300	–	–	0.03%	204
2023 Q4	$239K	Buy	+6,300	New	+$135K	0.04%	177

Other funds holding INBX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HCR Wealth Advisors's INBX Position: Q2 2024 in Review

HCR Wealth Advisors sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 6,300 shares — an estimated $220K sold.

HCR Wealth Advisors first reported a position in INBX in Q4 2023 and held it in 2 quarters. The position peaked at $239K in Q4 2023. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

HCR Wealth Advisors reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
HCR Wealth Advisors sold 6,300 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $220K.
HCR Wealth Advisors first reported a position in Inhibrx, Inc. Common Stock in Q4 2023 and held it in 2 quarters.
HCR Wealth Advisors's Inhibrx, Inc. Common Stock position peaked at $239K in Q4 2023.
2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on HCR Wealth Advisors's 13F filing for Q2 2024, filed 7 Aug 2024.